Key facts
- This page summarizes Simon H. Stertzer's Form 4 filing for BioCardia, Inc. (BCDA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jun 2026, 18:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
This transaction was executed in multiple trades ranging from $0.90 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Footnote F2
This transaction was executed in multiple trades ranging from $1.00 to $1.01 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Footnote F3
These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.
Footnote F4
These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers.
Footnote F5
These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.
Footnote F6
These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.